Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,034.79 +16.40 (+0.33%) Dow
38,053.53 +150.24 (+0.40%) Nasdaq
15,712.15 +106.67 (+0.68%) Bitcoin USD
59,336.31 +2,314.02 (+4.06%) CMC Crypto 200
1,276.85 +6.11 (+0.48%)
ABT Jan 2026 125.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:44AM EDT. Market open.
| Previous close | 12.95 |
| Open | 12.90 |
| Bid | 16.50 |
| Ask | 19.05 |
| Strike | 125.00 |
| Expiry date | 2026-01-16 |
| Day's range | 12.90 - 12.95 |
| Contract range | N/A |
| Volume | |
| Open interest | 54 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.